Absci to participate in the b. riley securities' life sciences tools conference - proteomics setting the blueprint for innovative drug creation

Vancouver, wash. and new york, march 23, 2023 (globe newswire) -- absci corporation (nasdaq: absi), a generative ai drug creation company, today announced the company will be participating virtually in the upcoming b. riley securities' life sciences tools conference - proteomics setting the blueprint for innovative drug creation.
ABSI Ratings Summary
ABSI Quant Ranking